Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in neonatal hypoxic-ischemic encephalopathy
NCT01059461Phase 2Completed
- Start
- Mar 2011
- Primary completion
- Sep 2013
- Modality
- Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cerebrolysin in hypoxic-ischemic encephalopathy (HIE). Started Mar 2011; status: completed.
02
Drugs
cerebrolysin
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT01059461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059461.